202 related articles for article (PubMed ID: 36918560)
1. BRD9-mediated chromatin remodeling suppresses osteoclastogenesis through negative feedback mechanism.
Du J; Liu Y; Wu X; Sun J; Shi J; Zhang H; Zheng A; Zhou M; Jiang X
Nat Commun; 2023 Mar; 14(1):1413. PubMed ID: 36918560
[TBL] [Abstract][Full Text] [Related]
2. BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4.
Ahmed NS; Gatchalian J; Ho J; Burns MJ; Hah N; Wei Z; Downes M; Evans RM; Hargreaves DC
Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34983841
[TBL] [Abstract][Full Text] [Related]
3. The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9.
Klein DC; Lardo SM; Hainer SJ
Cancer Res Commun; 2024 Jan; 4(1):237-252. PubMed ID: 38126767
[TBL] [Abstract][Full Text] [Related]
4. BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state.
Xiao M; Kondo S; Nomura M; Kato S; Nishimura K; Zang W; Zhang Y; Akashi T; Viny A; Shigehiro T; Ikawa T; Yamazaki H; Fukumoto M; Tanaka A; Hayashi Y; Koike Y; Aoyama Y; Ito H; Nishikawa H; Kitamura T; Kanai A; Yokoyama A; Fujiwara T; Goyama S; Noguchi H; Lee SC; Toyoda A; Hinohara K; Abdel-Wahab O; Inoue D
Nat Commun; 2023 Dec; 14(1):8372. PubMed ID: 38102116
[TBL] [Abstract][Full Text] [Related]
5. BRD9-mediated control of the TGF-β/Activin/Nodal pathway regulates self-renewal and differentiation of human embryonic stem cells and progression of cancer cells.
Wang X; Song C; Ye Y; Gu Y; Li X; Chen P; Leng D; Xiao J; Wu H; Xie S; Liu W; Zhao Q; Chen D; Chen X; Wu Q; Chen G; Zhang W
Nucleic Acids Res; 2023 Nov; 51(21):11634-11651. PubMed ID: 37870468
[TBL] [Abstract][Full Text] [Related]
6. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.
Zhao B; Grimes SN; Li S; Hu X; Ivashkiv LB
J Exp Med; 2012 Feb; 209(2):319-34. PubMed ID: 22249448
[TBL] [Abstract][Full Text] [Related]
7. BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming.
Sevinç K; Sevinç GG; Cavga AD; Philpott M; Kelekçi S; Can H; Cribbs AP; Yıldız AB; Yılmaz A; Ayar ES; Arabacı DH; Dunford JE; Ata D; Sigua LH; Qi J; Oppermann U; Onder TT
Stem Cell Reports; 2022 Dec; 17(12):2629-2642. PubMed ID: 36332631
[TBL] [Abstract][Full Text] [Related]
8. Bromodomain containing 9 (BRD9) regulates macrophage inflammatory responses by potentiating glucocorticoid receptor activity.
Wang L; Oh TG; Magida J; Estepa G; Obayomi SMB; Chong LW; Gatchalian J; Yu RT; Atkins AR; Hargreaves D; Downes M; Wei Z; Evans RM
Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34446564
[TBL] [Abstract][Full Text] [Related]
9. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
[TBL] [Abstract][Full Text] [Related]
10. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
Alpsoy A; Dykhuizen EC
J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
[TBL] [Abstract][Full Text] [Related]
11. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption.
Zheng H; Yu X; Collin-Osdoby P; Osdoby P
J Biol Chem; 2006 Jun; 281(23):15809-20. PubMed ID: 16613848
[TBL] [Abstract][Full Text] [Related]
12. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.
Remillard D; Buckley DL; Paulk J; Brien GL; Sonnett M; Seo HS; Dastjerdi S; Wühr M; Dhe-Paganon S; Armstrong SA; Bradner JE
Angew Chem Int Ed Engl; 2017 May; 56(21):5738-5743. PubMed ID: 28418626
[TBL] [Abstract][Full Text] [Related]
13. BRD9 is a druggable component of interferon-stimulated gene expression and antiviral activity.
Börold J; Eletto D; Busnadiego I; Mair NK; Moritz E; Schiefer S; Schmidt N; Petric PP; Wong WW; Schwemmle M; Hale BG
EMBO Rep; 2021 Oct; 22(10):e52823. PubMed ID: 34397140
[TBL] [Abstract][Full Text] [Related]
14. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.
Wang X; Wang S; Troisi EC; Howard TP; Haswell JR; Wolf BK; Hawk WH; Ramos P; Oberlick EM; Tzvetkov EP; Ross A; Vazquez F; Hahn WC; Park PJ; Roberts CWM
Nat Commun; 2019 Apr; 10(1):1881. PubMed ID: 31015438
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition.
Ali MM; Naz S; Ashraf S; Knapp S; Ul-Haq Z
Int J Biol Macromol; 2023 Mar; 230():123428. PubMed ID: 36709803
[TBL] [Abstract][Full Text] [Related]
16. Babam2 negatively regulates osteoclastogenesis by interacting with Hey1 to inhibit Nfatc1 transcription.
Jin F; Zhu Y; Liu M; Wang R; Cui Y; Wu Y; Liu G; Wang Y; Wang X; Ren Z
Int J Biol Sci; 2022; 18(11):4482-4496. PubMed ID: 35864959
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.
Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D
Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074
[TBL] [Abstract][Full Text] [Related]
18. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
[TBL] [Abstract][Full Text] [Related]
19. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
[TBL] [Abstract][Full Text] [Related]
20. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.
Weisberg E; Chowdhury B; Meng C; Case AE; Ni W; Garg S; Sattler M; Azab AK; Sun J; Muz B; Sanchez D; Toure A; Stone RM; Galinsky I; Winer E; Gleim S; Gkountela S; Kedves A; Harrington E; Abrams T; Zoller T; Vaupel A; Manley P; Faller M; Chung B; Chen X; Busenhart P; Stephan C; Calkins K; Bonenfant D; Thoma CR; Forrester W; Griffin JD
Blood Cancer J; 2022 Jul; 12(7):110. PubMed ID: 35853853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
